BackItem 9 Labs Overview
Item 9 Labs Corp.

Item 9 Labs Return on Equity

Valuation check: INLB's ROE is -58.91%, below the sector sector average of 11.64%.

Get informed when a big investor buys or sells

+ Follow

ROE

-58.91%

Return on Equity

-58.91%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Item 9 Labs (INLB) FAQ

Item 9 Labs posts a ROE of -58.91%. That is below the sector sector average of 11.64%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For its sector stocks, a ROE near 11.64% is typical. Item 9 Labs's -58.91% is lower that level. That is roughly 606.2% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Item 9 Labs's ROE moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -58.91%; use YoY and peer views to separate noise from signal.

Context for INLB's ROE usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 11.64%), and (3) consistency with growth and profitability. This page covers the first two; Item 9 Labs's other metric pages and overview cover the third.